glp 1 for chronic kidney disease GLP-1 receptor agonists' impact on cardio-renal outcomes and mortality in T2D with acute GLP-1 receptor agonists in patients

What do these medications have in common and how are they different

Inhibition of GLP-1R in the NTS (by Ex9) prevents Ex4 from executing its attenuation of alcohol-induced hyperlocomotion (Vallof et al., 2019b), which indicates that circulating GLP-1 may act via NTS to regulate alcohol responses

A safer mindset A better question than Am I allowed to drink? is: What happens in my body now if I drink? Start slower, eat first, and watch for symptoms that matter instead of testing old limits

GLP-1 is released postprandially by intestinal L cells and its activation of GLP-1 receptors (GLP-1Rs) on cells stimulates insulin biosynthesis/secretion